These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34884269)

  • 1. Circulating Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1): A Diagnostic Indicator across the Spectrum of Acute Coronary Syndrome.
    Kumar S; Ali W; Mishra S; Pradhan A; Sethi R; Kushwaha R; Singh US; Perrone MA
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome.
    Stankova T; Delcheva G; Maneva A; Vladeva S
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31443320
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis.
    Hayashida K; Kume N; Murase T; Minami M; Nakagawa D; Inada T; Tanaka M; Ueda A; Kominami G; Kambara H; Kimura T; Kita T
    Circulation; 2005 Aug; 112(6):812-8. PubMed ID: 16061745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography.
    Kobayashi N; Takano M; Hata N; Kume N; Yamamoto M; Yokoyama S; Shinada T; Tomita K; Shirakabe A; Otsuka T; Seino Y; Mizuno K
    Int J Cardiol; 2013 Oct; 168(4):3217-23. PubMed ID: 23632121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study.
    Kume N; Mitsuoka H; Hayashida K; Tanaka M; Kita T
    Circ J; 2010 Jul; 74(7):1399-404. PubMed ID: 20467154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse cardiovascular events: A multicentre pilot study.
    Zhao ZW; Xu YW; Li SM; Guo JJ; Yi T; Chen LL
    Biochem Med (Zagreb); 2019 Feb; 29(1):010705. PubMed ID: 30799974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with angiographic coronary lesion complexity in patients with coronary artery disease.
    Zhao ZW; Zhu XL; Luo YK; Lin CG; Chen LL
    Clin Cardiol; 2011 Mar; 34(3):172-7. PubMed ID: 21400544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease.
    Kott KA; Genetzakis E; Gray MP; Hansen P; McGuire HM; Yang JY; Grieve SM; Vernon ST; Figtree GA
    Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with erectile dysfunction in patients without known coronary artery disease.
    Kobat MA; Fırdolas F; Balin M; Çelik A; Bentli R; Baydas A
    J Sex Med; 2013 Nov; 10(11):2782-9. PubMed ID: 23088332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Utility of Soluble Lectin Type Oxidized Low-Density Lipoprotein Receptor as a Biomarker for Myocardial Infarction and Stable Angina.
    Narsini R; Bhaskar V; Luqman H; O SS; Parupati SSR; B V RRA; Krishna Mohan I
    Cureus; 2023 Dec; 15(12):e50719. PubMed ID: 38234947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble lectin-like oxidized LDL receptor-1 and high-sensitivity troponin T as diagnostic biomarkers for acute coronary syndrome. Improved values with combination usage in emergency rooms.
    Kobayashi N; Hata N; Kume N; Shinada T; Tomita K; Shirakabe A; Kitamura M; Nozaki A; Inami T; Seino Y; Mizuno K
    Circ J; 2011; 75(12):2862-71. PubMed ID: 21937834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes.
    Kraler S; Wenzl FA; Georgiopoulos G; Obeid S; Liberale L; von Eckardstein A; Muller O; Mach F; Räber L; Losdat S; Schmiady MO; Stellos K; Stamatelopoulos K; Camici GG; Srdic A; Paneni F; Akhmedov A; Lüscher TF
    Eur Heart J; 2022 May; 43(19):1849-1860. PubMed ID: 35567560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) and sLOX-1/oxidized LDL ratio as novel biomarkers of acute coronary syndrome.
    Hussein RA; Abdul-Rasheed OF; Basheer M
    Acta Biochim Pol; 2022 Apr; 69(2):309-314. PubMed ID: 35389578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of monoclonal antibodies against a soluble form of lectin-like oxidized low-density lipoprotein receptor-1 and development of a sensitive chemiluminescent enzyme immunoassay.
    Nakamura M; Ohta H; Kume N; Hayashida K; Tanaka M; Mitsuoka H; Kaneshige T; Misaki S; Imagawa K; Shimosako K; Ogawa N; Kita T; Kominami G
    J Pharm Biomed Anal; 2010 Jan; 51(1):158-63. PubMed ID: 19632802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention.
    Zhao ZW; Xu YW; Li SM; Guo JJ; Sun JM; Hong JC; Chen LL
    Dis Markers; 2019; 2019():4925767. PubMed ID: 31772687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels predict percutaneous coronary intervention-related periprocedural myocardial infarction in stable patients undergoing elective native single-vessel PCI.
    Balin M; Celik A; Kobat MA; Baydas A
    J Thromb Thrombolysis; 2012 Nov; 34(4):483-90. PubMed ID: 22797935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulatory soluble LOX-1 is a novel predictor for coronary artery disease patients.
    Sheikh MSA
    Cardiovasc J Afr; 2023 May-Jun 23; 34(2):104-108. PubMed ID: 36218037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease.
    Kamezaki F; Yamashita K; Tasaki H; Kume N; Mitsuoka H; Kita T; Adachi T; Otsuji Y
    Int J Cardiol; 2009 May; 134(2):285-7. PubMed ID: 18367271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum sLOX-1 levels are associated with the presence and severity of angiographic coronary artery disease in patients with metabolic syndrome.
    Li B; Zhang LH; Yang XG; Liu XT; Ren YG
    Clin Invest Med; 2010 Dec; 33(6):E398-404. PubMed ID: 21134342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of Soluble Lectin-Like Low-Density Lipoprotein Receptor-1 (sLOX-1) With Inflammation and Coronary Plaque Progression in Psoriasis.
    Florida EM; Li H; Hong CG; Ongstad EL; Gaddipati R; Sitaula S; Varma V; Parel PM; O'Hagan R; Chen MY; Teague HL; Playford MP; Karathanasis SK; Collén A; Mehta NN; Remaley AT; Sorokin AV
    J Am Heart Assoc; 2023 Nov; 12(22):e031227. PubMed ID: 37982276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.